×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Real-World Data Traceability: Challenges and Solutions When Generating Real-World Evidence
Session Chair(s)
James Browning, MPH
Director of Biostatistical Programming, Center for Observational Research
Amgen, United States
This session will engage an expert panel in a discussion on traceability of RWD. Panelists will describe challenges and discuss potential solutions to maintain and document traceability of RWD used in regulatory submissions.
Learning Objective : Describe the inherent challenges in maintaining and documenting the traceability of Real-World Data (RWD) for regulatory purposes; Explore potential solutions, including new and existing technologies, to enhance RWD traceability; Evaluate the strengths and weaknesses of various approaches to RWD traceability in a regulatory context.
Speaker(s)
Healthcare Organization Research Technology Perspective
Christopher Herrick
Mass General Brigham (MGB), United States
VP of Research Systems and Technology
Traceability - Tools & Implementation Perspective
Anand Shroff
Verantos, United States
President
Regulator Perspective
Representative Invited
FDA, United States
Real-World Data Provider Perspective
Eric Fontana
Optum, United States
Epidemiologist/Observational Researcher Perspective
Nancy A Dreyer, PhD, MPH, FISPE
Dreyer Strategies LLC, United States
Founder
Have an account?